Gene · 171221
NIH grants1,959
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,959
Download this page as JSON| Grant | Title | DNAJB1P1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI110762 | Molecular Mechanisms of HBV cccDNA Formation | 1 | 2025 |
| R01AI134818 | The Role of HBeAg in HBV Persistence | 1 | 2025 |
| R01AI168166 | Defining the Interplay Between Viral Adaptation and Host Proteostasis | 1 | 2025 |
| R01AI171289 | Role of Type I IFN Signaling in Seoul Orthohantavirus Pathogenesis | 1 | 2025 |
| R01AI171514 | Structure-based microbially targeted prodrugs | 1 | 2025 |
| R01AR073201 | Bridging the gap between GWAS and mechanism in arthritis | 1 | 2025 |
| R01CA051497 | Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis | 1 | 2025 |
| R01CA062130 | Role of heat shock transcription factor HSF1 in tumorigenesis | 1 | 2025 |
| R01CA102184 | Functional Analysis of p53 Polymorphic Variants | 1 | 2025 |
| R01CA129933 | Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells | 1 | 2025 |
| R01CA141244 | Allosteric Regulation of MDMX by Protein Disorder | 1 | 2025 |
| R01CA251253 | Modulating HSP70/STUB1 machinery in therapy-resistant prostate cancer | 1 | 2025 |
| R01CA252055 | Regulation of DGAT - dependent lipogenesis in colonic epithelial growth | 1 | 2025 |
| R01CA260356 | Anti-tumor potential of temperature-sensitive p53 mutants | 1 | 2025 |
| R01CA268183 | Ctr9 as a Predictive Biomarker for EZH2 Inhibitor Sensitivity | 1 | 2025 |
| R01DC008853 | Functional development of hair cells and neurons in the inner ear | 1 | 2025 |
| R01DE017102 | TRPC1, Calcium, and Saliva Secretion | 1 | 2025 |
| R01DE019638 | The role of continuous phenotypic variation in structural defects of the face | 1 | 2025 |
| R01DK054231 | Molecular of ROMK Channel Function | 1 | 2025 |
| R01DK078760 | The impact of HSP72 on mitochondrial function and muscle metabolism | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/171221/grants?page=9